Standard Chartered provides $200m for Africa's vaccine procurement

AstraZeneca/Oxford Covid-19 coronavirus vaccine

 A nurse holds up a vial of the AstraZeneca/Oxford Covid-19 coronavirus vaccine on July 9, 2021. PHOTO | MADAREE TOHLALA | AFP

Standard Chartered Bank said on Thursday it is providing $200 million in not-for-profit funding to the African Export-Import Bank's (Afreximbank)  Covid-19 vaccine procurement framework for Africa.

The facility is part of Afreximbank's Advance Procurement Commitment framework, under which it has provided a $2 billion guarantee to manufacturers to secure access to vaccine doses for African nations, Standard Chartered said in statement.